PHOTONIC PHARMA

Photonic Pharma LLC is pleased to announce that it was awarded its second SBIR Phase I grant from the National Institute on Aging at the National Institutes of Health related to new therapeutic avenues for treatment of Alzheimer's disease... At Photonic Pharma LLC, we focus on the early phase of drug development - Lead Discovery - using a game-changing technology platform that combines breakthroughs in fluorescent biosensor engineering and fluorescence lifetime detection in living cells. Thus we achieve a dramatic 30-fold increase in the precision of high-throughput screening of small-molecule libraries, with the potential to transform the productivity of pharmaceutical development.

Also known as: Photonic Pharma LLC

Primary location: Minneapolis United States